RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

Given how slow and unpredictable getting the data together has proven to be this far, it wouldn't make a lot of sense on MV's part to give a date for when the last data point would be collected. We've been waiting 5 months for a handful of subjects to enroll and complete.

Regarding the signal, if the signal were really clear and obvious, it would have made sense to unblind the trial and take what they could get. They may have seen a trend in the data, but what people see in their data -- particularly when there is a lot riding on it -- isn't always validated by statistical analysis.